Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guus Fons

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Reproductive Medicine|October 17, 2002
Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot studyManon van Seters, Guus Fons, Marc van Beurden
The Cochrane Database of Systematic Reviews|May 13, 2011
Primary groin irradiation versus primary groin surgery for early vulvar cancerJacobus van der Velden, Guus Fons, Theresa A Lawrie
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 3, 2008
Validation of tissue microarray technology in vulvar cancerGuus Fons, Jacobus van der Velden, Matthe Burger, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 7, 2007
Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarraysGuus Fons, Matthe P Burger, Fiebo J Ten Kate, et al.
Journal of Clinical Pathology|July 11, 2006
Validation of tissue microarray technology in endometrioid cancer of the endometriumGuus Fons, Siti M Hasibuan, Jacobus van der Velden, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Assessment of promising protein markers for vulva cancerGuus Fons, Matthé P M Burger, Fiebo J W ten Kate, et al.
Cancers|August 12, 2023
Selective Removal of Only Clinically Suspicious Positive Lymph Nodes Instead of a Complete Inguino-Femoral Lymph Node Dissection in Squamous Cell Carcinoma of the VulvaGuus Fons, Nikki B Thuijs, Ming Tjiong, et al.
BMJ Open|August 17, 2024
Patients' preferences, experiences and expectations with wait time until surgery in gynaecological oncology: a mixed-methods study in two gynaecological oncological centres in the NetherlandsKim van den Berg, Anne Knegt, Guus Fons, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 10, 2009
The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective studyTaghride Dahhan, Guus Fons, Marrije R Buist, et al.
Fertility and Sterility|September 22, 2009
The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serumSimone Marnitz, Alexander Schmittel, Juliane Bolbrinker, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Reproductive Medicine|October 17, 2002
Imiquimod in the treatment of multifocal vulvar intraepithelial neoplasia 2/3. Results of a pilot studyManon van Seters, Guus Fons, Marc van Beurden
The Cochrane Database of Systematic Reviews|May 13, 2011
Primary groin irradiation versus primary groin surgery for early vulvar cancerJacobus van der Velden, Guus Fons, Theresa A Lawrie
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 3, 2008
Validation of tissue microarray technology in vulvar cancerGuus Fons, Jacobus van der Velden, Matthe Burger, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 7, 2007
Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarraysGuus Fons, Matthe P Burger, Fiebo J Ten Kate, et al.
Journal of Clinical Pathology|July 11, 2006
Validation of tissue microarray technology in endometrioid cancer of the endometriumGuus Fons, Siti M Hasibuan, Jacobus van der Velden, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Assessment of promising protein markers for vulva cancerGuus Fons, Matthé P M Burger, Fiebo J W ten Kate, et al.
Cancers|August 12, 2023
Selective Removal of Only Clinically Suspicious Positive Lymph Nodes Instead of a Complete Inguino-Femoral Lymph Node Dissection in Squamous Cell Carcinoma of the VulvaGuus Fons, Nikki B Thuijs, Ming Tjiong, et al.
BMJ Open|August 17, 2024
Patients' preferences, experiences and expectations with wait time until surgery in gynaecological oncology: a mixed-methods study in two gynaecological oncological centres in the NetherlandsKim van den Berg, Anne Knegt, Guus Fons, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 10, 2009
The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective studyTaghride Dahhan, Guus Fons, Marrije R Buist, et al.
Fertility and Sterility|September 22, 2009
The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serumSimone Marnitz, Alexander Schmittel, Juliane Bolbrinker, et al.
Pageof 3